{
    "version": "1.0",
    "type": "rich",
    "width": "",
    "height": "",
    "title": "Euroopa Ravimiamet andis müügiloa ravimile LEQVIO® (inklisiraan), mis on esimene kaks korda aastas annustatav siRNA klassi kuuluv ravim kolesteroolitaseme langetamiseks*",
    "url": "https://beta.med24.ee/partnerite-uudised/euroopa-ravimiamet-andis-mueuegiloa-ravimile-leqvio-inklisiraan-mis-on-esimene-kaks-korda-aastas-annustatav-sirna-klassi-kuuluv-ravim-kolesteroolitaseme-langetamiseks/287408",
    "author_name": "med24",
    "author_url": "https://beta.med24.ee",
    "provider_name": "Labrador",
    "provider_url": "http://www.labradorcms.com/",
    "html": "<div class=\"labrador-cms-embed\" data-lab-style=\" dac-embed-full\" data-lab-content=\"full\" data-lab-id=\"287408\" data-lab-site=\"beta.med24.ee\"><script async defer src=\"https://beta.med24.ee/embed.js?v=335\"></script></div>"
}